Back to Search Start Over

Disease-linked TDP-43 hyperphosphorylation suppresses TDP-43 condensation and aggregation.

Authors :
Gruijs da Silva LA
Simonetti F
Hutten S
Riemenschneider H
Sternburg EL
Pietrek LM
Gebel J
Dötsch V
Edbauer D
Hummer G
Stelzl LS
Dormann D
Source :
The EMBO journal [EMBO J] 2022 Apr 19; Vol. 41 (8), pp. e108443. Date of Electronic Publication: 2022 Feb 03.
Publication Year :
2022

Abstract

Post-translational modifications (PTMs) have emerged as key modulators of protein phase separation and have been linked to protein aggregation in neurodegenerative disorders. The major aggregating protein in amyotrophic lateral sclerosis and frontotemporal dementia, the RNA-binding protein TAR DNA-binding protein (TDP-43), is hyperphosphorylated in disease on several C-terminal serine residues, a process generally believed to promote TDP-43 aggregation. Here, we however find that Casein kinase 1δ-mediated TDP-43 hyperphosphorylation or C-terminal phosphomimetic mutations reduce TDP-43 phase separation and aggregation, and instead render TDP-43 condensates more liquid-like and dynamic. Multi-scale molecular dynamics simulations reveal reduced homotypic interactions of TDP-43 low-complexity domains through enhanced solvation of phosphomimetic residues. Cellular experiments show that phosphomimetic substitutions do not affect nuclear import or RNA regulatory functions of TDP-43, but suppress accumulation of TDP-43 in membrane-less organelles and promote its solubility in neurons. We speculate that TDP-43 hyperphosphorylation may be a protective cellular response to counteract TDP-43 aggregation.<br /> (© 2022 The Authors. Published under the terms of the CC BY 4.0 license.)

Details

Language :
English
ISSN :
1460-2075
Volume :
41
Issue :
8
Database :
MEDLINE
Journal :
The EMBO journal
Publication Type :
Academic Journal
Accession number :
35112738
Full Text :
https://doi.org/10.15252/embj.2021108443